Neuroscience
positron emission tomographic scan
100%
Positron Emission Tomography
74%
Antipsychotic
57%
Meta-Analysis
42%
Fluorine-18
36%
Translocator Protein
26%
Glutamic Acid
24%
Antidepressant
19%
In Vivo
18%
Cannabinoid 1 Receptor
18%
Placebo
16%
Functional Magnetic Resonance Imaging
14%
Blood Plasma
13%
Dopaminergic
13%
Mental Disorder
13%
Magnetic Resonance Imaging
12%
Major Depressive Disorder
12%
Metabolic Pathway
12%
Methyltransferase
12%
Phosphodiesterase
12%
Molecular Imaging
12%
Emapunil
10%
Negative Syndrome
9%
Body Mass Index
9%
Nervous System Disorder
9%
Nuclear Magnetic Resonance Spectroscopy
8%
Cannabis
8%
Cannabinoid
8%
Parkinson's Disease
7%
Hypothalamus
7%
Stereotypic Movement Disorder
7%
Gray Matter Volume
7%
Longitudinal Study
7%
Clozapine
7%
Hallucination
7%
Receptor
6%
Substantia nigra
6%
Lipopolysaccharide
6%
Thalamus
6%
Posterior Cingulate
6%
Dynamic Functional Connectivity
6%
Serotonin
6%
Citalopram
6%
N-Acetylaspartic Acid
6%
Brain Abnormalities
6%
Individual Differences
6%
Prolactin
6%
Synaptic Vesicle
6%
Vesicular Monoamine Transporter
6%
Fight-or-Flight Response
6%
Medicine and Dentistry
Positron Emission Tomography
43%
Antipsychotic
29%
Polyethylene Terephthalate
27%
Radioactive Tracer
21%
Mitochondrial Membrane Transport Protein
18%
Diseases
17%
Fluorine-18
15%
Meta-Analysis
12%
Glutamic Acid
12%
Carbon 11
10%
Biological Marker
9%
Emapunil
8%
Treatment Response
8%
Body Mass Index
8%
Early Intervention
8%
Clozapine
7%
Cross Sectional Study
7%
Mental Health
7%
Hallucination
7%
Functional Magnetic Resonance Imaging
6%
Mild Cognitive Impairment
6%
Tau
6%
PET-MRI
6%
Amyloid Protein
6%
Systematic Review
6%
Cardiometabolic Risk
6%
Sensory Gating
6%
High-Risk Population
6%
Electroencephalogram
6%
Conditioning
6%
Severe Mental Illness
6%
Vesicular Monoamine Transporter
6%
Metabolic Syndrome
6%
Nerve Potential
6%
Influenza Vaccine
6%
Pharmacogenomics
6%
Psychiatry
6%
Tamsulosin
6%
Autonomic Nervous System
6%
Major Depressive Episode
6%
Radiomics
6%
Ventral Striatum
6%
Substantia nigra
6%
Ventral Tegmental Area
6%
Midbrain
6%
Alzheimer's Disease
5%
Clinician
5%
Dopamine Metabolism
5%